Dupont Capital Management Corp Viatris Inc Transaction History

Dupont Capital Management Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	SELL	$9.02 - $10.29 $13,349 - $15,229	-1,480 Reduced 10.2%	13,023 $129,000
Q1 2023 Apr 28, 2023	SELL	$9.2 - $12.26 $1.17 Million - $1.56 Million	-127,143 Reduced 89.76%	14,503 $139,000
Q4 2022 Jan 26, 2023	BUY	$8.72 - $11.56 $1.23 Million - $1.63 Million	141,345 Added 46958.47%	141,646 $0
Q3 2022 Oct 31, 2022	SELL	$8.48 - $11.13 $772,646 - $1.01 Million	-91,114 Reduced 99.67%	301 $3,000
Q2 2022 Jul 26, 2022	BUY	$9.95 - $12.27 $155,170 - $191,350	15,595 Added 20.57%	91,415 $957,000
Q1 2022 Apr 27, 2022	BUY	$9.81 - $15.4 $554,186 - $869,976	56,492 Added 292.28%	75,820 $825,000
Q4 2021 Jan 31, 2022	BUY	$12.09 - $14.68 $233,675 - $283,735	19,328 New	19,328 $262,000
Q3 2021 Nov 03, 2021	SELL	$13.25 - $15.13 $203,308 - $232,154	-15,344 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$12.97 - $16.15 $5,110 - $6,363	394 Added 2.64%	15,344 $219,000
Q1 2021 Apr 29, 2021	SELL	$13.59 - $18.54 $62,310 - $85,005	-4,585 Reduced 23.47%	14,950 $209,000
Q4 2020 Jan 28, 2021	BUY	$14.3 - $18.74 $279,350 - $366,085	19,535 New	19,535 $366,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.